140 related articles for article (PubMed ID: 27690729)
1. Endothelin-1 receptor drives invadopodia: Exploiting how β-arrestin-1 guides the way.
Bagnato A; Rosanò L
Small GTPases; 2018 Sep; 9(5):394-398. PubMed ID: 27690729
[TBL] [Abstract][Full Text] [Related]
2. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
[TBL] [Abstract][Full Text] [Related]
3. Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer.
Chellini L; Caprara V; Spadaro F; Sestito R; Bagnato A; Rosanò L
Matrix Biol; 2019 Aug; 81():17-33. PubMed ID: 30367951
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK.
Masi I; Caprara V; Spadaro F; Chellini L; Sestito R; Zancla A; Rainer A; Bagnato A; Rosanò L
Cell Rep; 2021 Mar; 34(9):108800. PubMed ID: 33657382
[TBL] [Abstract][Full Text] [Related]
5. hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.
Di Modugno F; Caprara V; Chellini L; Tocci P; Spadaro F; Ferrandina G; Sacconi A; Blandino G; Nisticò P; Bagnato A; Rosanò L
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3132-3137. PubMed ID: 29439204
[TBL] [Abstract][Full Text] [Related]
6. β-arrestin1 at the cross-road of endothelin-1 signaling in cancer.
Rosanò L; Bagnato A
J Exp Clin Cancer Res; 2016 Jul; 35(1):121. PubMed ID: 27473335
[TBL] [Abstract][Full Text] [Related]
7. The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer.
Masi I; Ottavi F; Del Rio D; Caprara V; Vastarelli C; Giannitelli SM; Fianco G; Mozetic P; Buttarelli M; Ferrandina G; Scambia G; Gallo D; Rainer A; Bagnato A; Spadaro F; Rosanò L
Cell Death Dis; 2023 Jan; 14(1):73. PubMed ID: 36717550
[TBL] [Abstract][Full Text] [Related]
8. Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer.
Rosanò L; Cianfrocca R; Sestito R; Tocci P; Di Castro V; Bagnato A
Expert Opin Ther Targets; 2017 Oct; 21(10):925-932. PubMed ID: 28758529
[TBL] [Abstract][Full Text] [Related]
9. Methods to Investigate β-Arrestin-1/β-Catenin Signaling in Ovarian Cancer Cells.
Rosanò L; Cianfrocca R; Bagnato A
Methods Mol Biol; 2019; 1957():393-406. PubMed ID: 30919368
[TBL] [Abstract][Full Text] [Related]
10. β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer.
Tocci P; Cianfrocca R; Di Castro V; Rosanò L; Sacconi A; Donzelli S; Bonfiglio S; Bucci G; Vizza E; Ferrandina G; Scambia G; Tonon G; Blandino G; Bagnato A
Nat Commun; 2019 Jul; 10(1):3196. PubMed ID: 31324767
[TBL] [Abstract][Full Text] [Related]
11. KISS1R signaling promotes invadopodia formation in human breast cancer cell via β-arrestin2/ERK.
Goertzen CG; Dragan M; Turley E; Babwah AV; Bhattacharya M
Cell Signal; 2016 Mar; 28(3):165-176. PubMed ID: 26721186
[TBL] [Abstract][Full Text] [Related]
12. Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy.
Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Caprara V; Semprucci E; Ferrandina G; Natali PG; Bagnato A
Cancer Res; 2014 Dec; 74(24):7453-64. PubMed ID: 25377471
[TBL] [Abstract][Full Text] [Related]
13. A novel spatiotemporal RhoC activation pathway locally regulates cofilin activity at invadopodia.
Bravo-Cordero JJ; Oser M; Chen X; Eddy R; Hodgson L; Condeelis J
Curr Biol; 2011 Apr; 21(8):635-44. PubMed ID: 21474314
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1/endothelin A receptor axis activates RhoA GTPase in epithelial ovarian cancer.
Tocci P; Caprara V; Cianfrocca R; Sestito R; Di Castro V; Bagnato A; Rosanò L
Life Sci; 2016 Aug; 159():49-54. PubMed ID: 26776837
[TBL] [Abstract][Full Text] [Related]
15. A RhoG-mediated signaling pathway that modulates invadopodia dynamics in breast cancer cells.
Goicoechea SM; Zinn A; Awadia SS; Snyder K; Garcia-Mata R
J Cell Sci; 2017 Mar; 130(6):1064-1077. PubMed ID: 28202690
[TBL] [Abstract][Full Text] [Related]
16. CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Hoffmann C; Mao X; Dieterle M; Moreau F; Al Absi A; Steinmetz A; Oudin A; Berchem G; Janji B; Thomas C
Oncotarget; 2016 Mar; 7(12):13688-705. PubMed ID: 26883198
[TBL] [Abstract][Full Text] [Related]
17. Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase.
Cianfrocca R; Rosanò L; Spinella F; Di Castro V; Natali PG; Bagnato A
Can J Physiol Pharmacol; 2010 Aug; 88(8):796-801. PubMed ID: 20725137
[TBL] [Abstract][Full Text] [Related]
18. Differential role for PAK1 and PAK4 during the invadopodia lifecycle.
Nicholas NS; Pipili A; Lesjak MS; Wells CM
Small GTPases; 2019 Jul; 10(4):289-295. PubMed ID: 28301299
[TBL] [Abstract][Full Text] [Related]
19. β3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells.
Peláez R; Morales X; Salvo E; Garasa S; Ortiz de Solórzano C; Martínez A; Larrayoz IM; Rouzaut A
PLoS One; 2017; 12(8):e0181579. PubMed ID: 28767724
[TBL] [Abstract][Full Text] [Related]
20. Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer.
Cianfrocca R; Rosanò L; Tocci P; Sestito R; Caprara V; Di Castro V; De Maria R; Bagnato A
Cell Death Differ; 2017 Oct; 24(10):1811-1820. PubMed ID: 28708138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
